Stay updated on CIN-107 in Primary Aldosteronism Clinical Trial
Sign up to get notified when there's something new on the CIN-107 in Primary Aldosteronism Clinical Trial page.

Latest updates to the CIN-107 in Primary Aldosteronism Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has undergone significant content removal, particularly regarding the detailed study protocol for CIN-107 in patients with Primary Aldosteronism, including treatment duration and inclusion/exclusion criteria. The revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference29%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to January 22, 2025.SummaryDifference0.4%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check88 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check95 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to CIN-107 in Primary Aldosteronism Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CIN-107 in Primary Aldosteronism Clinical Trial page.